Supplement: The Disease

The Disease ARTICLE EXTRAS Living with Schizophrenia Robin Cunningham Marianne Emanuel A Very Expensive Disease Schizophrenia in Childhood This year, some 600,000 people will be diagnosed with schizophrenia. That's 600,000 lives - and many times that when you consider their families - thrown into what some have described as a living hell. People with the disease are far more likely to be jobless, ill with other diseases, and commit suicide. So it is approp

Written byThe Scientist
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Living with Schizophrenia

Robin Cunningham

Marianne Emanuel

A Very Expensive Disease

Schizophrenia in Childhood

This year, some 600,000 people will be diagnosed with schizophrenia. That's 600,000 lives - and many times that when you consider their families - thrown into what some have described as a living hell. People with the disease are far more likely to be jobless, ill with other diseases, and commit suicide.

So it is appropriate that we begin this supplement with stories of living with this terrible disease. On the following pages, you will read about Robin Cunningham, who has suffered from schizophrenia since the age of 13. Cunningham's story is an inspiring one. Now 65, he is retired from a career in finance, and spends his days advocating for those with the disease.

You'll also read about Marianne Emanuel, a nurse who has dedicated her career to caring for those with schizophrenia. Their stories ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies